Attention Deficit/Hyperactivity Disorder (ADHD) in children: Rationale for its integrative management

Alternative Medicine Review

Volumn 5, Issue 5, 2000, Pages 402-428

  Kidd, P M ^a  

^a NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE; CLONIDINE; DESOXYN GRADUMET; DEXAMPHETAMINE; ESSENTIAL FATTY ACID; FLAVONOID; FOOD ADDITIVE; GUANFACINE; IRON; MAGNESIUM; METAL; METHAMPHETAMINE; METHYLPHENIDATE; MINERAL; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PEMOLINE; PEMOLINE MAGNESIUM; PHOSPHATIDYLSERINE; PSYCHOSTIMULANT AGENT; PYRIDOXINE; THYROID HORMONE; VITAMIN; ZINC;

ATTENTION DEFICIT DISORDER; CHILD; CLINICAL FEATURE; DIET THERAPY; DISEASE COURSE; DOPAMINERGIC SYSTEM; ENVIRONMENTAL FACTOR; HUMAN; NERVE CELL DIFFERENTIATION; NEUROBIOLOGY; PATHOGENESIS; PRACTICE GUIDELINE; PRESCHOOL CHILD; REVIEW; RISK BENEFIT ANALYSIS; SCHOOL CHILD; VITAMIN SUPPLEMENTATION;

ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; AVITAMINOSIS; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; ENVIRONMENTAL ILLNESS; FATTY ACIDS, ESSENTIAL; FOOD ADDITIVES; HUMANS; METALS; METHYLPHENIDATE; VITAMINS;

EID: 0033766412     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (141)

1. Complementary medicine approaches to ADHD
2. Childhood hyperactivity
3. Attention deficit hyperactivity disorder: Advances in cognitive, neurobiological, and genetic research
4. Some abnormal psychical conditions in children
5. Introductory remarks
6. More frequent diagnosis of attention deficit-hyperactivity disorder
7. Diagnosing attention-deficit/hyperactivity disorder in children
8. Estimates of the prevalence of childhood maladjustment in a community survey in Puerto Rico
9. Diagnosis and treatment of attention-deficit/hyperactivity disorder in children and adolescents
10. A new PET ligand for the dopamine transporter: Studies in the human brain
11. Is methylphenidate like cocaine?
12. Dopamine transporter occupancies in the human brain induced by therapeutic doses of oral methylphenidate
13. The hazards of treating ADHD with Ritalin
14. Rating scales in attention-deficit/hyperactivity disorder: Use in assessment and treatment monitoring
15. Comorbidity of attention deficit hyperactivity disorder with conduct, depressive, anxiety and other disorders
16. Attention-deficit/hyperactivity disorder: A life-span perspective
17. Pharmacotherapy of attention-deficit hyperactivity disorder
18. Psychopharmacology of ADHD: Children and adolescents
19. When teens fall apart
20. Another risk for kids? Lots of them on Prozac
21. An outline of hazardous side effects of Ritalin (methylphenidate)
22. Therapeutic effects of medication on ADHD: Implications for school psychologists
23. Experimental studies on the long-term effects of methylphenidate hydrochloride
24. Prevalence and implications of attention-deficit hyperactivity disorder among adolescents in treatment for substance abuse
25. Effects of environmental synthetic chemicals on thyroid function
26. Further evidence for family-genetic risk factors in attention deficit hyperactivity disorder
27. Family-environment risk factors for attention-deficit hyperactivity disorder
28. High risk for Attention Deficit Hyperactivity disorder among children of parents with childhood onset of the disorder: A pilot study
29. Genetic influence on parent-reported attention-related problems
30. What is ADHD?
31. Familial aggregation of emotional and behavioral problems of childhood in the general population
32. Attention-deficit hyperactivity disorder: A category or a continuum? Genetic analysis of a large-scale twin study
33. Attention deficit hyperactivity disorder dimensions: A twin study of inattention and impulsivity-hyperactivity
34. Quantitative brain magnetic resonance imaging in attention-deficit hyperactivity disorder
35. Neuropathic manifestations in infants and children as a result of anaphylactic reactions to foods contained in their diet
36. Diet and behavior in children
37. Foods and additives are common causes of the attention deficit hyperactive disorder in children
38. Food and chemical intolerance: Placebo-controlled studies in attention deficit disorders
39. Placebo-controlled tests of chemical food additives: Are they valid?
40. Food additives and hyperactive children: A critique of Conners
41. Food additives and hyperkinesis: A controlled double-blind experiment
42. The effects of sugar on behavior and cognition in children: A meta-analysis
43. Behavioral responses to artificial food colors
44. Food additives and environmental chemicals as sources of childhood behavior disorders
45. Systemic manifestations due to allergy
46. Can what a child eats make him dull, stupid, or hyperactive?
47. Sugar and children's behavior
48. Sugar, yeast and ADHD: Fact or fiction?
49. Controlled trial of oligoantigenic treatment in the hyperkinetic syndrome
50. Controlled trial of hyposensitisation in children with food-induced hyperkinetic syndrome
51. Does diet affect hyperactivity?
52. Food allergy treatment for hyperkinesis
53. Effects of a few food diet in attention deficit disorder
54. Salicylates, oligoantigenic diets, and behaviour
55. Dietary correlates of hyperactive behavior in children
56. Glucose tolerance and hyperkinesis
57. Lead and hyperactivity. Behavioral response to chelation: A pilot study
58. Main and interaction effects of metallic pollutants on cognitive functioning
59. Low-level lead exposure and children's IQ: A meta-analysis and search for a threshold
60. Hair lead levels related to children's classroom attention-deficit behavior
61. Levels and combinations of metallic toxins and measures of behavioral disturbance
62. Hair mineral content as a predictor of learning disabilities
63. Hair mineral analysis and behavior: An analysis of 51 studies
64. Environmental medicine, Part 1: The human burden of environmental toxins and their common health effects
65. The human/wildlife/laboratory connection
66. Childhood exposures to pesticides affecting the CNS: Lessons from pesticide management
67. The adverse effects of food additives on health: A review of the literature with special emphasis on childhood hyperactivity
68. Low-level exposures to chemicals: Challenges for research and policy
69. Interactions of persistent environmental organohalogens with the thyroid hormone system: Mechanisms and possible consequences for animal and human health
70. Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child
71. Attention-deficit hyperactivity disorder and thyroid function
72. Low intelligence but not attention deficit hyperactivity disorder is associated with resistance to thyroid hormone caused by mutation R316H in the thyroid hormone receptor B gene
73. Abnormalities in sustained attention and anterior cingulate metabolism in subjects with resistance to thyroid hormone
74. Attention deficit-hyperactivity disorder in people with generalized resistance to thyroid hormone
75. Effects of in utero exposure to polychlorinated biphenyls and related contaminants on cognitive functioning in young children
76. Intellectual impairment in children exposed to polychlorinated biphenyls in utero
77. Effects of dioxins and polychlorinated biphenyls on thyroid hormone status of pregnant women and their infants
78. Organochlorine endocrine disruptors in human tissue
79. Prenatal exposure to polychlorinated biphenyls: Effects on birth size and gestational age
80. Urinary catecholamines in attention-deficit hyperactivity disorder with and without comorbid anxiety
81. Catecholamines in attention-deficit hyperactivity disorder: Current perspectives
82. Implication of right frontostriatal circuitry in response inhibition and attention-deficit/hyperactivity disorder
83. Quantitative morphology of the caudate nucleus in attention deficit hyperactivity disorder
84. Cerebral glucose metabolism in adolescent girls with attention-deficit hyperactivity disorder
85. Striatal dysfunction in attention deficit and hyperkinetic disorder
86. Cerebral glucose metabolism in adults with hyperactivity of childhood onset
87. Brain metabolism in teenagers with attention-deficit hyperactivity disorder
88. SPECT brain imaging anomalies in attention deficit hyperactivity disorder
89. Attention-deficit hyperactivity disorder
90. A review of five nutrients and botanicals in the integrative management of cognitive dysfunction
91. Nutritional supplementation for ADHD
92. Nutritional deficiencies and behavior
93. Megavitamins for minimal brain dysfunction
94. The effect of pyridoxine hydrochloride on blood serotonin and pyridoxal phosphate contents in hyperactive children
95. The effects of megadoses of selected B complex vitamins on children with hyperkinesis: Controlled studies with long-term follow-up
96. A preliminary study of the effect of pyridoxine
97. Iron treatment in children with attention deficit hyperactivity disorder. A preliminary report
98. Assessment of magnesium level in children with attention deficit hyperactivity disorder
99. The effects of magnesium physiological supplementation on hyperactivity in children with attention deficit hyperactivity disorder (ADHD)
100. Relationships between serum free fatty acids and zinc, and attention deficit hyperactivity disorder: A research note
101. Does hair zinc predict amphetamine improvement of ADD/hyperactivity?
102. Are long-chain polyunsaturated fatty acids essential nutrients in infancy?
103. A lack of essential fatty acids as a possible cause of hyperactivity in children
104. Clinical characteristics and serum essential fatty acid levels in hyperactive children
105. Essential fatty acid metabolism in boys with attention-deficit hyperactivity disorder
106. Omega-3 fatty acids in boys with behavior, learning, and health problems
107. The effects of essential fatty acid supplementation by Efamol in hyperactive children
108. Gamma-linolenic acid for attention deficit hyperactivity disorder: Placebo-controlled comparison to D-amphetamine
109. Long-chain polyunsaturated fatty acids in children with attention-deficit hyperactivity disorder
110. 2-dimethylaminoethanol (deanol): A brief review of its clinical efficacy and postulated mechanism of action
111. Mood alterations during deanol therapy
112. Benefits of PS (phosphatidylserine) against attention deficit in a preliminary study
113. Plasma amino acids and attention deficit disorder
114. Amino acid precursors for the treatment of attention deficit disorder, residual type
115. An open trial of L-tyrosine in the treatment of attention deficit disorder, residual type
116. S-adenosyl methionine (SAM) in adults with ADHD: Preliminary results from an open trial
117. Dark adaptation, motor skills, docosahexaenoic acid, and dyslexia
118. Nutritional supplements in ADHD
119. Effects of nutritional supplementation on attention-deficit disorder
120. Foods, food additives, and behavior
121. Attention-deficit hyperactivity disorder: Magnetic resonance imaging morphometric analysis of the corpus callosum
122. The effect of dietary supplementation with evening primrose oil on hyperkinetic children